1. Straightforward synthesis of a novel ring-fused pyrazole-lactam and in vitro cytotoxic activity on cancer cell lines
- Author
-
Andrea Mazzanti, Giulio Bertuzzi, M. Comes Franchini, David Colecchia, Pierpaolo Calandro, Mario Chiariello, Paolo Zani, Bianca F. Bonini, Erica Locatelli, Jay Zumbar Chandanshive, Bertuzzi, G., Locatelli, E., Colecchia, D., Calandro, P., Bonini, B.F., Chandanshive, J.Z., Mazzanti, A., Zani, P., Chiariello, M., and Comes Franchini, M
- Subjects
Nitrile ,Lactams ,Stereochemistry ,Imine ,Amino Acids, Cyclic ,Antineoplastic Agents ,Pyrazole ,010402 general chemistry ,01 natural sciences ,chemistry.chemical_compound ,Cell Line, Tumor ,Drug Discovery ,Nitriles ,Side chain ,Humans ,Pharmacology ,Cycloaddition Reaction ,010405 organic chemistry ,Drug Discovery3003 Pharmaceutical Science ,Organic Chemistry ,General Medicine ,Anticancer drug ,Cycloaddition ,In vitro ,0104 chemical sciences ,chemistry ,1,3-Dipolar cycloaddition ,Drug Design ,Lactam ,Pyrazoles ,Imines - Abstract
In this paper a straightforward synthesis of a novel pyrazole derivative is reported. Prominent feature of this synthetic process is a 1,3-Dipolar Cycloaddition of a suitable nitrile imine with an activated α,β-unsaturated lactam to afford directly and regioselectively the corresponding ring-fused pyrazole. Having obtained the central core of the synthetic target, a double stepwise functionalization with a “side chain” characterized by a terminal cyclic aliphatic amine was carried out. This molecular structure was designed to interact strongly with typical biological residues, and indeed it showed potent anticancer capability: in vitro cytotoxicity test on five different cancer cell lines showed interesting IC50 values in the range of 15–60 μM for exposure time of 24–72 h, thus resulting comparable with commercially available and nowadays therapeutically exploited anticancer compounds, such as 5-FU and NVP-BEZ235.
- Published
- 2015